By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Bioethics Commission Calls for More Communication, Proactivity When Dealing with Incidental Findings
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Policy & Law > Medical Ethics > Bioethics Commission Calls for More Communication, Proactivity When Dealing with Incidental Findings
Medical EthicsPolicy & LawPublic Health

Bioethics Commission Calls for More Communication, Proactivity When Dealing with Incidental Findings

Deanna Pogorelc
Deanna Pogorelc
Share
3 Min Read
SHARE

Molecular testing

First published on MedCityNews.com.

Molecular testing

First published on MedCityNews.com.

More Read

Book Review: Reading In the Brain
Cause Marketing: Autism Awareness Month
The Diagnosis That Could Have You Paying an Extra $40,000 Per Patient
The Uncertainty of Breast Surgery
Overtreatment Alert! Antibiotics Fuel Medical Overutilization

The hullabaloo around 23andMe brought to light one unresolved issue for direct-to-consumer testing companies, and now a federal advisory panel is bringing to light another: dealing with incidental findings.

Incidental findings are pieces of information that are happened upon by clinicians, researchers or DTC testing companies during a test or procedure. For example, a child who’s had an on-the-field collision has an MRI to check for brain damage. Instead, radiologists find a small growth that could potentially be cancerous.

Of course these kinds of findings can be lifesaving in some cases. But in others they could be distressing. Say a young woman enrolls in a study that involves having her genome sequenced to look for variants that indicate she’s at-risk for developing breast cancer. In the process, researchers find a variant that might suggest she’s at risk for a genetic condition which has no cure. Is it that company’s responsibility to tell her? Does she want to know?

As technology advances, these tough decisions resulting from a routine test, from participation in research or from having a genome sequenced are likely to become more common.

“Practitioners seem to be getting conflicting advice about how to manage these findings,” explained Amy Gutmann, chairwoman of the Presidental Commission for the Study of Bioethical Issues, in a call with reporters on Wednesday.

To set the course for action, the commission put together a 160-page report that details the importance of shared decision-making between practitioners and patients before such tests are given.

The report doesn’t prescribe specific plans as to how they should go about that. “Prescribing a single plan would be a mistake,” Gutmann explained. Instead, the commission came up with five broad recommendations:

  • Clinicians, researchers and genetic testing companies should inform participants/patients of the potential of incidental findings before the test is administered and devise a plan for dealing with them.
  • Professional groups should develop guidelines for their members that categorize likely incidental findings and establish best practices for managing them.
  • Federal agencies should continue to fund research on the potential costs, benefits and harms of identifying incidental and secondary findings, to develop evidence that will inform decisions about how to manage them.
  • Public and private entities should prepare educational materials for practitioners, IRBs and potential recipients of incidental findings.
  • All individuals must have access to the necessary information and guidance needed to make informed choices about what tests to undergo and what to do with the information once received. Existing disparities could lead to unequal access to the counseling and care needed to deal with findings.

The report gets a little more specific in is recommendations for providers, researchers and DTC companies. You can read it in full here.

Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

dental care
Importance of Good Dental Care for Health and Confidence
Dental health Specialties
October 2, 2025
AI in Healthcare
AI in Healthcare: Technology is Transforming the Global Landscape
Global Healthcare Policy & Law Technology
October 1, 2025
Choosing the Right Swimwear for Health and Safety
News
September 30, 2025
sports concussions
Concussion In Sports: How Common They Are And What You Need To Know
Infographics
September 28, 2025

You Might also Like

Medical EthicsMedical Records

A Guide to Medical Billing Services for Small Practices

January 26, 2022
unnecessary medical tests
DiagnosticsHospital AdministrationPolicy & Law

Eagerly Awaiting the Death of Defensive Medicine

September 5, 2013
Health careWellness

6 Tips for Taking Care of Your Mental Health When Working Abroad

November 23, 2018
health reform
BusinessHealth Reform

Can Downton Abbey “Health Plan” Replace Obamacare?

April 29, 2013
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?